chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.
To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with chlortetracycline
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
BERESTON ES and CARLINER PE | The treatment of a case of Kaposi's varicelliform eruption with aureomycin. | 1949 | J. Invest. Dermatol. | pmid:18133468 |
DOWLING HF and LEPPER MH | Aureomycin in various infections; report of 180 cases and review of the clinical literature. | 1949 | Med Ann Dist Columbia | pmid:18133899 |
PENALVER BALLINA R | [Not Available]. | 1949 | Bol Soc Cubana Dermatol Sifilogr | pmid:18134648 |
Ransmeier JC | THE EFFECT OF AUREOMYCIN AGAINST BACTERIUM TULARENSE. | 1949 | J. Clin. Invest. | pmid:16695772 |
Demerec M | PATTERNS OF BACTERIAL RESISTANCE TO PENICILLIN, AUREOMYCIN, AND STREPTOMYCIN. | 1949 | J. Clin. Invest. | pmid:16695757 |
Gezon HM and Fasan DM | ANTIGENIC AND ENZYME SYSTEM CHANGES IN BETA HEMOLYTIC STREPTOCOCCI RESISTANT TO PENICILLIN, STREPTOMYCIN, BACITRACIN AND AUREOMYCIN. | 1949 | J. Clin. Invest. | pmid:16695756 |
Harvey JC et al. | CLINICAL EXPERIENCE WITH AUREOMYCIN. | 1949 | J. Clin. Invest. | pmid:16695774 |
LONG PH and SCHOENBACH EB | The experimental and clinical use of polymyxin, chloromycetin, and aureomycin. | 1949 | Calif Med | pmid:18112450 |
APPELMAN HB and HALE AS | Aureomycin in dendritic keratitis; case report. | 1949 | J Mich State Med Soc | pmid:18113957 |
ANIGSTEIN L et al. | Aureomycin; protective effect in experimental Rocky Mountain spotted fever and typhus with particular reference to intermittent treatment. | 1949 | Tex. Rep. Biol. Med. | pmid:18114264 |
HERRELL WE and HEILMAN FR | Aureomycin studies on absorption, diffusion and excretion. | 1949 | Proc Staff Meet Mayo Clin | pmid:18115523 |
SCARZELLA M et al. | [Not Available]. | 1949 | Minerva Med. | pmid:18146356 |
BOUYQUES P | [Not Available]. | 1949 | Paris Med | pmid:18146676 |
WOODWARD TE | Chloromycetin and aureomycin; therapeutic results. | 1949 | Ann. Intern. Med. | pmid:18146884 |
GRATER WC and RIDER JA | Lymphocytic choriomeningitis; treatment of two cases with aureomycin. | 1949 | Tex State J Med | pmid:18147033 |
DI GANGI FE and ROGERS CH | Adsorption studies of aureomycin hydrochloride on aluminum hydroxide gel. | 1949 | J Am Pharm Assoc Am Pharm Assoc | pmid:15398560 |
TROUTMAN EG and FLESHER MO | Aureomycin; a review. | 1949 | Univ South Calif Bull Sch Med | pmid:18137622 |
DE GENNES L and BRICAIRE H | [Not Available]. | 1949 | Presse Med | pmid:18118740 |
LONG PH | The present status of polymyxin, chloromycetin and aureomycin; experimental and clinical. | 1949 | Am J Pharm Sci Support Public Health | pmid:18118956 |
JUKES RF | Aureomycin in infections of the urinary tract. | 1949 | Ohio Med | pmid:18119525 |